Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Minerva Endocrinologica|May 20, 1998
Hypopituitarism and antiphospholipid syndromeC Pandolfi, A Gianini, V Fregoni, et al.
Cancer Chemotherapy and Pharmacology|March 27, 2015
Targeting the EWS-FLI1 transcription factor in Ewing sarcomaR Tancredi, A Zambelli, G A DaPrada, et al.
Blood|January 1, 1992
Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders. Results of a phase I/II clinical trialM Cazzola, L Ponchio, Y Beguin, et al.
Oncology Reports|June 19, 1998
Paclitaxel in anthracycline-treated breast cancer patientsP Pugliese, S Brugnatelli, M Giordano, et al.
International Journal of Oncology|March 16, 2000
Doubling of the epirubicin dosage within the 5-fluorouracil, epirubicin and cyclophosphamide regimen: a prospective, randomized, multicentric study on antitumor effect and quality of life in advanced breast cancerA Riccardi, C Tinelli, S Brugnatelli, et al.
Bone Marrow Transplantation|March 7, 2003
Cytotoxic chemotherapy preceding apheresis of peripheral blood progenitor cells can affect the early reconstitution phase of naive T cells after autologous transplantationF F Fagnoni, L Lozza, C Zibera, et al.
Tumori|December 23, 1998
Myeloprotective effect of early primary granulocyte-colony stimulating factor during six courses of intensified 5-fluorouracil, epirubicin and cyclophosphamide (120FEC) chemotherapy for advanced breast cancer. Cooperative Group of Study and Treatment of Breast CancerA Riccardi, S Brugnatelli, M Giordano, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 3, 2005
Incidence of human cytomegalovirus infection in patients with refractory solid tumors receiving nonmyeloablative allogeneic stem cell transplants versus recipients of standard SCT for hematologic malignanciesA Zambelli, D Lilleri, P Pedrazzoli, et al.
Pageof 1